Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
14.06
-1.49 (-9.58%)
May 14, 2025, 4:00 PM - Market closed

Korro Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-87.41-83.58-81.17-58.03-21.96
Depreciation & Amortization
4.063.573.632.511.6
Loss (Gain) From Sale of Assets
0.360.360.07-0.01
Loss (Gain) From Sale of Investments
-2.12-1.78-0.08-0.150.02
Stock-Based Compensation
5.364.462.381.140.81
Other Operating Activities
2.273.313.611.51-13.47
Change in Accounts Receivable
-1.92-1.7---
Change in Accounts Payable
1.34-1.343.11.760.06
Change in Unearned Revenue
8.89.43---0.69
Change in Other Net Operating Assets
6.637.21.18-2.391.53
Operating Cash Flow
-62.64-60.07-67.28-53.65-32.09
Capital Expenditures
-12.41-17.9-7.84-5.21-4.45
Sale of Property, Plant & Equipment
----0.01
Investment in Securities
-72.55-105.451916.27-35.07
Investing Cash Flow
-84.96-123.3511.1611.06-39.5
Issuance of Common Stock
69.3969.36154.550.060.03
Other Financing Activities
---12.25-0.04-0.03
Financing Cash Flow
69.3969.36187.760.02115.95
Foreign Exchange Rate Adjustments
-0-0---
Net Cash Flow
-78.21-114.07131.64-42.5744.35
Free Cash Flow
-75.05-77.98-75.12-58.86-36.54
Free Cash Flow Margin
-1556.63%-3433.55%---
Free Cash Flow Per Share
-8.10-8.74-49.12-230.65-8.22
Cash Income Tax Paid
0.120.140.030.01-
Levered Free Cash Flow
-61.34-69.99-47.69-38.2-
Unlevered Free Cash Flow
-61.34-69.99-47.69-38.2-
Change in Net Working Capital
-1.332.68-6.97-0.24-
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q